| scholarly article | Q13442814 |
| P50 | author | Steve Meaney | Q39908482 |
| Ingemar Björkhem | Q39908514 | ||
| Kristian Winge | Q48359267 | ||
| P2093 | author name string | Per Svenningsson | |
| Valerio Leoni | |||
| Anita Lövgren-Sandblom | |||
| Sven Pålhagen | |||
| Lovisa Brodin | |||
| Lisette Salveson | |||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Parkinson's disease | Q11085 |
| cerebrospinal fluid | Q54196 | ||
| P304 | page(s) | 102-105 | |
| P577 | publication date | 2013-09-10 | |
| P1433 | published in | Neuroscience Letters | Q7002625 |
| P1476 | title | Oxysterols and Parkinson's disease: evidence that levels of 24S-hydroxycholesterol in cerebrospinal fluid correlates with the duration of the disease | |
| P478 | volume | 555 |
| Q38335068 | 24(S)-Hydroxycholesterol as a Modulator of Neuronal Signaling and Survival |
| Q91725869 | 24(S)-Hydroxycholesterol induces ER dysfunction-mediated unconventional cell death |
| Q58758885 | 24S-Hydroxycholesterol Correlates With Tau and Is Increased in Cerebrospinal Fluid in Parkinson's Disease and Corticobasal Syndrome |
| Q36323801 | 24S-hydroxycholesterol and 25-hydroxycholesterol differentially impact hippocampal neuronal survival following oxygen-glucose deprivation |
| Q37457270 | 7α-hydroxy-3-oxo-4-cholestenoic acid in cerebrospinal fluid reflects the integrity of the blood-brain barrier. |
| Q64073771 | Association between carotid plaque and Parkinson's disease |
| Q64782430 | Brain cholesterol metabolism and Parkinson's disease |
| Q38271572 | Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease. |
| Q38289739 | Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases |
| Q90005109 | Cholesterol 24-Hydroxylation by CYP46A1: Benefits of Modulation for Brain Diseases |
| Q101237500 | Cholesterol metabolism and brain injury in neonatal encephalopathy |
| Q36249577 | Cholesterolomics: An update |
| Q36284241 | Elevated GM3 plasma concentration in idiopathic Parkinson's disease: A lipidomic analysis |
| Q92104918 | GRP78 Level Is Altered in the Brain, but Not in Plasma or Cerebrospinal Fluid in Parkinson's Disease Patients |
| Q36983489 | Higher Plasma LDL-Cholesterol is Associated with Preserved Executive and Fine Motor Functions in Parkinson's Disease |
| Q33767544 | Integrated molecular landscape of Parkinson's disease |
| Q36618692 | Interindividual Variability in Cytochrome P450-Mediated Drug Metabolism |
| Q38285578 | Lipidomic analysis of cerebrospinal fluid by mass spectrometry-based methods |
| Q26774242 | New methods for analysis of oxysterols and related compounds by LC-MS |
| Q64860569 | Nuclear Receptors as Therapeutic Targets for Neurodegenerative Diseases: Lost in Translation |
| Q55248842 | Oxysterol levels and metabolism in the course of neuroinflammation: insights from in vitro and in vivo models. |
| Q40438996 | Reduced Plasma Levels of 25-Hydroxycholesterol and Increased Cerebrospinal Fluid Levels of Bile Acid Precursors in Multiple Sclerosis Patients. |
| Q91992373 | Sterolomics in biology, biochemistry, medicine |
| Q58779935 | Stomaching the Possibility of a Pathogenic Role for Helicobacter pylori in Parkinson's Disease |
| Q38666817 | Synaptic proteins in CSF relate to Parkinson's disease stage markers |
| Q61804251 | The Role of Lipids in Parkinson's Disease |
| Q35856120 | The oxysterol and cholestenoic acid profile of mouse cerebrospinal fluid. |
| Q91593341 | α-synuclein-lipoprotein interactions and elevated ApoE level in cerebrospinal fluid from Parkinson's disease patients |
Search more.